Introduction

Insulin resistance is one of the earliest metabolic changes associated with the development of type 2 diabetes and several other chronic health conditions.

It often develops gradually over many years without causing obvious symptoms.

As a result, many people are unaware they have insulin resistance until routine blood tests reveal changes in blood glucose levels or they are diagnosed with prediabetes or type 2 diabetes.

Today, insulin resistance is recognised as an important focus of preventive medicine because early identification of metabolic risk factors provides opportunities to support long-term health before more serious complications develop.

Fortunately, insulin resistance is influenced by a combination of genetic, environmental and lifestyle factors, many of which can be modified through evidence-based medical care and healthy lifestyle habits.

In this article, we explain what insulin resistance is, why it develops, who may be at increased risk and how it is assessed as part of a comprehensive medical evaluation.

What Is Insulin?

Insulin is a hormone produced by specialised cells in the pancreas.

Its primary role is to help regulate blood glucose (blood sugar) levels.

After eating, carbohydrates are broken down into glucose, which enters the bloodstream.

In response, the pancreas releases insulin.

Insulin acts like a key, allowing glucose to move from the bloodstream into the body's cells, where it is used as a source of energy or stored for future use.

This process helps maintain blood glucose within a healthy range.

In addition to regulating glucose, insulin also plays important roles in:

• Fat metabolism.
• Protein metabolism.
• Energy storage.
• Cell growth and repair.

Under normal circumstances, the body carefully adjusts insulin production according to its metabolic needs.

What Is Insulin Resistance?

Insulin resistance occurs when the body's cells become less responsive to insulin.

As a result, more insulin is required to achieve the same effect.

In the early stages, the pancreas compensates by producing larger amounts of insulin to keep blood glucose levels within the normal range.

During this period, blood glucose may remain normal even though insulin levels are elevated.

Over time, however, the pancreas may no longer be able to produce enough insulin to overcome this resistance.

When this happens, blood glucose levels begin to rise, increasing the risk of developing prediabetes and eventually type 2 diabetes.

Insulin resistance develops gradually and usually reflects the combined influence of multiple genetic, metabolic and lifestyle factors rather than a single underlying cause.

Why Does Insulin Resistance Matter?

Insulin resistance is important because its effects extend well beyond blood sugar regulation.

Research has shown that insulin resistance is associated with an increased risk of several chronic health conditions, including:

• Prediabetes.
• Type 2 diabetes.
• Cardiovascular disease.
• Metabolic syndrome.
• Non-alcoholic fatty liver disease.
• Polycystic ovary syndrome (PCOS).

Not everyone with insulin resistance will develop these conditions.

However, identifying insulin resistance early provides an opportunity to address modifiable risk factors and support long-term metabolic health.

For this reason, insulin resistance has become an important focus of preventive medicine.

Who Is Most at Risk?

Insulin resistance can affect individuals of all ages, although certain factors increase the likelihood of developing it.

Recognised risk factors include:

• Overweight and obesity, particularly excess abdominal fat.
• Physical inactivity.
• Family history of type 2 diabetes.
• Increasing age.
• Prediabetes.
• Gestational diabetes during pregnancy.
• Polycystic ovary syndrome (PCOS).
• High blood pressure.
• Abnormal cholesterol levels.
• Certain ethnic backgrounds.

Having one or more risk factors does not necessarily mean a person has insulin resistance.

Likewise, some individuals without obvious risk factors may still develop it.

A comprehensive medical assessment helps evaluate each person's individual level of risk.

Early Warning Signs

One of the challenges of insulin resistance is that it often causes no symptoms during its early stages.

Many people feel completely well while important metabolic changes are already taking place.

When symptoms or clinical features do occur, they may include:

• Increased waist circumference.
• Difficulty losing weight.
• Fatigue, particularly after meals.
• Increased hunger.
• Cravings for sugary foods.
• Elevated blood pressure.
• Abnormal cholesterol levels.

Some individuals may also develop acanthosis nigricans, a condition characterised by darker, velvety patches of skin that commonly appear on the neck, underarms or groin and can be associated with insulin resistance.

These findings are not specific to insulin resistance and may occur in many other medical conditions.

For this reason, they should always be evaluated within the context of a comprehensive medical assessment rather than interpreted in isolation.

Why Early Detection Is Important

Insulin resistance often develops silently over many years before blood glucose levels become abnormal.

This gradual progression provides an opportunity for early identification of metabolic risk factors through appropriate medical assessment.

Recognising insulin resistance before the onset of type 2 diabetes allows physicians and patients to focus on evidence-based strategies that support metabolic health, including lifestyle interventions and, when clinically indicated, medical treatment.

Rather than waiting for complications to develop, preventive medicine aims to identify individuals at increased risk and provide personalised recommendations that promote long-term health.

Causes and Risk Factors

Insulin resistance develops through a complex interaction of genetic, environmental and lifestyle factors.

Rather than having a single cause, it usually results from multiple influences that gradually affect the body's ability to respond normally to insulin.

Recognised risk factors include:

• Excess body fat, particularly around the abdomen.
• Physical inactivity.
• Family history of type 2 diabetes.
• Increasing age.
• Poor sleep quality.
• Chronic psychological stress.
• Certain hormonal disorders.
• Gestational diabetes.
• Polycystic ovary syndrome (PCOS).
• Some medications.

Although genetics influence susceptibility, lifestyle remains one of the most important modifiable factors associated with metabolic health.

It is also important to recognise that insulin resistance can occur in people with a normal body weight, although it is generally more common in individuals with overweight or obesity.

How Is Insulin Resistance Diagnosed?

There is no single routine blood test that directly diagnoses insulin resistance.

Instead, physicians evaluate insulin resistance by combining:

• Medical history.
• Physical examination.
• Body weight and waist circumference.
• Blood pressure.
• Family history.
• Laboratory investigations.
• Overall metabolic risk profile.

In research settings, specialised tests such as the hyperinsulinaemic-euglycaemic clamp are considered the reference standard for measuring insulin sensitivity.

However, these tests are complex, time-consuming and are not routinely used in everyday clinical practice.

Instead, physicians rely on a combination of clinical findings and laboratory results to assess metabolic health and estimate the likelihood of insulin resistance.

Blood Tests Used to Assess Metabolic Health

Although no single blood test confirms insulin resistance, several laboratory investigations help evaluate glucose regulation and overall metabolic health.

Depending on the clinical situation, these may include:

• Fasting blood glucose.
• HbA1c (glycated haemoglobin).
• Lipid profile.
• Liver function tests.
• Kidney function tests.
• Fasting insulin (in selected clinical situations).

In some cases, physicians may also calculate indices such as the Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) using fasting glucose and fasting insulin levels.

Although HOMA-IR can provide additional information in selected patients, it should always be interpreted within the broader clinical context and is not routinely required for everyone.

Laboratory investigations are most valuable when they are guided by the patient's symptoms, medical history and recognised risk factors.

Can Insulin Resistance Be Prevented?

Insulin resistance cannot always be prevented because genetics and ageing also influence metabolic health.

However, many of its modifiable risk factors can be addressed through healthy lifestyle habits and appropriate medical care.

Research consistently shows that preventive strategies aimed at improving overall metabolic health may reduce the risk of developing prediabetes and type 2 diabetes.

Preventive medicine focuses on identifying individuals at increased risk before complications develop, allowing earlier intervention when appropriate.

Lifestyle and Insulin Sensitivity

Healthy lifestyle habits play an important role in supporting normal insulin sensitivity.

Current evidence supports several approaches that benefit overall metabolic health.

Regular Physical Activity

Exercise improves the body's ability to use glucose efficiently.

Both aerobic exercise and resistance training have been shown to improve insulin sensitivity and support cardiovascular health.

Regular physical activity also contributes to maintaining a healthy body weight and preserving muscle mass.

Balanced Nutrition

A balanced dietary pattern that includes vegetables, fruits, whole grains, legumes, nuts, healthy fats and appropriate sources of protein supports overall metabolic health.

Rather than focusing on restrictive diets or eliminating individual foods, long-term healthy eating patterns are associated with better health outcomes.

Healthy Body Weight

For individuals who are overweight or obese, gradual and sustainable weight loss may improve insulin sensitivity and reduce the risk of progression to type 2 diabetes.

Even modest reductions in body weight have been associated with meaningful improvements in metabolic health.

Good Sleep

Sleep plays an important role in hormonal regulation and glucose metabolism.

Chronic sleep deprivation has been associated with reduced insulin sensitivity and an increased risk of metabolic disorders.

Maintaining regular sleep habits is therefore an important component of preventive healthcare.

Stress Management

Long-term psychological stress influences several hormonal pathways that affect metabolism.

Although stress alone does not cause insulin resistance, managing chronic stress may contribute to overall metabolic and cardiovascular health.

Common Myths About Insulin Resistance

Myth 1: Only people with obesity develop insulin resistance.

False.

Although obesity is an important risk factor, insulin resistance can also occur in individuals with a normal body weight.

Myth 2: Insulin resistance always causes symptoms.

False.

Many people have insulin resistance for years without noticing any symptoms.

This is why preventive medical assessment is so important.

Myth 3: High blood sugar means you already have diabetes.

False.

Blood glucose may remain within the normal range during the early stages of insulin resistance because the pancreas produces additional insulin to compensate.

Myth 4: Carbohydrates alone cause insulin resistance.

False.

Insulin resistance develops through the interaction of multiple factors, including genetics, body composition, physical activity, sleep, diet and overall metabolic health.

No single food or nutrient explains its development.

Myth 5: Insulin resistance can be diagnosed using one blood test.

False.

Diagnosis relies on a comprehensive evaluation that combines medical history, physical examination, laboratory findings and assessment of individual risk factors.

Personalised Metabolic Health Assessment at Dr. Indhira Ghyssaert's Practice in Mallorca

At Dr. Indhira Ghyssaert's practice in Mallorca, insulin resistance is assessed as part of a comprehensive evaluation of metabolic health rather than through a single laboratory result.

The consultation is designed to understand each patient's individual health profile, identify recognised risk factors and determine whether further investigations are clinically appropriate.

Depending on the patient's symptoms and medical history, the assessment may include:

• A detailed medical history.
• Lifestyle evaluation.
• Physical examination.
• Measurement of body weight and waist circumference.
• Blood pressure assessment.
• Review of cardiovascular risk factors.
• Laboratory investigations when clinically indicated.

Blood tests may help evaluate glucose regulation, cholesterol levels, liver and kidney function, and other aspects of metabolic health.

Results are always interpreted alongside the patient's symptoms, physical examination and overall clinical picture.

When appropriate, personalised recommendations may include lifestyle interventions, preventive strategies, additional investigations or referral to another healthcare professional.

The aim is to identify metabolic risk factors early and support long-term health through evidence-based, individualised care.

Frequently Asked Questions

What is the difference between insulin resistance and diabetes?

Insulin resistance occurs when the body's cells respond less effectively to insulin.

Type 2 diabetes develops when the pancreas can no longer produce enough insulin to maintain normal blood glucose levels.

Although insulin resistance often precedes type 2 diabetes, not everyone with insulin resistance will develop diabetes.

Can insulin resistance be reversed?

Research shows that improving lifestyle habits may significantly improve insulin sensitivity in many individuals.

However, outcomes vary depending on factors such as genetics, existing medical conditions and the duration of metabolic changes.

The goal is to improve metabolic health and reduce future health risks through personalised, evidence-based care.

What are the first signs of insulin resistance?

Many people experience no symptoms during the early stages.

When present, possible signs may include increased waist circumference, fatigue after meals, elevated blood pressure, abnormal cholesterol levels or areas of darkened skin known as acanthosis nigricans.

These findings are not specific to insulin resistance and should always be medically evaluated.

Should everyone be tested for insulin resistance?

Not necessarily.

Testing should be based on an individual's symptoms, medical history, family history and recognised risk factors rather than performed routinely in every person.

Is insulin resistance only related to body weight?

No.

Although excess body fat is an important risk factor, insulin resistance can also occur in people with a healthy body weight due to genetic, hormonal or other metabolic factors.

Key Takeaways

• Insulin resistance develops when the body's cells become less responsive to insulin.
• It often develops silently over many years before blood glucose levels become abnormal.
• Insulin resistance is associated with an increased risk of prediabetes, type 2 diabetes and cardiovascular disease.
• Diagnosis is based on a comprehensive medical assessment rather than a single laboratory test.
• Healthy lifestyle habits play an important role in supporting insulin sensitivity and long-term metabolic health.
• Early identification of metabolic risk factors allows timely preventive interventions.

Conclusion

Insulin resistance is a common metabolic condition that often develops gradually and without obvious symptoms.

Although it is closely associated with prediabetes and type 2 diabetes, its effects extend beyond blood sugar regulation and may influence cardiovascular health, liver health and overall metabolic wellbeing.

Because insulin resistance usually results from multiple interacting factors, assessment requires more than a single blood test.

A detailed medical history, physical examination, appropriate laboratory investigations and evaluation of individual risk factors provide a more complete understanding of metabolic health.

Early recognition offers an opportunity to address modifiable risk factors before more serious complications develop.

At Dr. Indhira Ghyssaert's practice in Mallorca, insulin resistance is evaluated through a personalised, evidence-based medical approach that supports prevention, early detection and long-term metabolic health.

About Dr. Indhira Ghyssaert

Dr. Indhira Ghyssaert is a physician based in Mallorca with a special interest in personalised medicine, preventive healthcare and lifestyle medicine.

Her clinical approach combines comprehensive medical assessment with evidence-based medicine to evaluate metabolic health, identify individual risk factors and develop personalised strategies that support long-term wellbeing.

Medical Disclaimer

The information provided in this article is intended for educational purposes only and should not replace professional medical advice, diagnosis or treatment.

Insulin resistance should be evaluated by a qualified healthcare professional as part of a comprehensive medical assessment. Decisions regarding laboratory investigations, diagnosis and treatment should always be based on an individual's clinical history, physical examination and current evidence-based medical guidelines.